Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Discover what to know about cash back and taxes to manage your finances better. Stay informed and make wise decisions.
28,655 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
A software company named by Deloitte as North America’s fastest-growing is rolling out a new model that pays users fo...
When a growth stock down nearly 50% from its high looks tempting, it helps to separate hype from fundamentals. This g...
Vanguard’s 8-for-1 split lowered VGT’s price, letting smaller investors pursue income strategies through covered call...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...
Barrick mining stock sinking this week is a reminder that miners ride metal prices as much as earnings. Here’s what’s...
A leading AI software name slammed in a broad market rotation now sits well off its highs. This guide breaks down whe...
Value stocks are resurging as inflation cools and markets favor durable cash flow. This piece examines why Vanguard M...
Oil edges toward a $100 threshold as geopolitical tensions intensify. Four key energy names—Exxon, Chevron, ConocoPhi...
Market swings can rattle your nerves, but they don’t have to derail your finances. This guide shows how to stay calm ...
New York hotel operators signed an eight-year labor agreement that lifts wages by about 50% and increases operating c...
Brent crude traded around $97.5 per barrel at 9 a.m. ET on May 28, 2026, keeping the focus on the current price 2026....